DaShenLin Pharmaceutical Group Co., Ltd.

Research DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) on Bullrun: market cap CNY 21.19B, P/E 15.6, dividend yield 4.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker603233.SS
ExchangeSS
CountryChina
SectorHealthcare
IndustryPharmaceutical Retailers
CurrencyCNY
Market capCNY 21.19B
P/E15.6
Dividend yield4.6%
Financial periodQ2 2026
RevenueCNY 7.02B
Net incomeCNY 415.56M
Free cash flowCNY 122.09M
Gross margin35.2%

Valuation Snapshot

latest market cap is CNY 21.19B; P/E is 15.6; dividend yield is 4.6%.

Peer valuation comparison

Latest P/E is 15.64x versus a Healthcare sector median of 21.69x (27.9% below).

Latest dividend yield is 4.55% versus a Healthcare sector median of 2.41% (88.8% above).

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	CNY 21.19B	15.6	4.4%	0.82

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.82 CNY, yield 4.6%.

About DaShenLin Pharmaceutical Group Co., Ltd.

DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Kingworld Medicines Group Limited (1110.HK) Shanghai Pioneer Holding Ltd (1345.HK) Universal Health International Group Holding Limited (2211.HK) Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Fangzhou Inc. (6086.HK) New Ray Medicine International Holding Limited (6108.HK) JD Health International Inc. (6618.HK) YSB Inc. (9885.HK) Pomdoctor Ltd (POM) Ridgetech Inc (RDGT) Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ)

Frequently asked questions

What is DaShenLin Pharmaceutical Group Co., Ltd.'s market cap?

DaShenLin Pharmaceutical Group Co., Ltd.'s market capitalization is CNY 21.19B.

What is DaShenLin Pharmaceutical Group Co., Ltd.'s P/E ratio?

DaShenLin Pharmaceutical Group Co., Ltd.'s price-to-earnings (P/E) ratio is 15.6.

Does DaShenLin Pharmaceutical Group Co., Ltd. pay a dividend?

DaShenLin Pharmaceutical Group Co., Ltd. has a dividend yield of 4.6%.